Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples